NCPDP Selects H1 as Exclusive Provider Data Partner
NCPDP’s robust prescriber database, HCIdea, is now powered by H1’s trusted provider data to help NCPDP members reduce costs and...
Financial
CERIS’ “The Pulse of Payment Integrity” Outlines New Claims Processing Path For Payers
Strengthening Process Boosts Revenue, Improves Provider RelationsFORT WORTH, Texas, April 11, 2023 (GLOBE NEWSWIRE) -- CERIS, a CorVel company, has...
Actuate Therapeutics Announces Poster Presentations at the 2023 AACR Annual Meeting
CHICAGO and FORT WORTH, Texas, April 10, 2023 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (Actuate), a clinical stage biopharmaceutical company,...
Predictive Oncology Announces Appointment of Oncology Translational Research Leader Christoph Reinhard, Ph.D., MBA, to its Scientific Advisory Board
EAGAN, Minn., April 04, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence...
OMNIMED™ Announces Integration of SmartOR™ Into Axis Research & Technologies Facilities
Roll-Out Across National Bioskills Training Centers Gives Med Device Companies and Surgeons Access to Intelligent Data-Driven Technology Platform and AI...
Healthcare Triangle Expands Long-Standing Customer Engagement with readabl.ai Medical Document Automation Solution
readabl.ai is a best-in-class AI and language processing model that help customers achieve maximum performance efficiency in workflow automationPLEASANTON, Calif.,...
Mydecine Reports Financial Results for the Year Ended December 2022
DENVER, March 31, 2023 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) ("Mydecine" or the "Company"),...
Transplant Logistics Leader MediGO Issues Statement Welcoming HRSA Announcement on Organ Procurement and Transplantation Network Modernization Initiative
BALTIMORE, March 30, 2023 (GLOBE NEWSWIRE) -- MediGO, a Baltimore-based digital healthcare supply chain technology company focused on improving equity,...
Predictive Oncology Announces Collaboration with Integra Therapeutics to Advance Gene Therapy
EAGAN, Minn., March 30, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a science-driven company on the leading edge of oncology...
OMNIMED Introduces New National Director of Technology
Medical technology company grows leadership team with promotion of Christian Loversky OMNIMED Introduces New National Director of Technology OMNIMED™, the medical...
Onconova Therapeutics and Pangea Biomed Enter into Research Collaboration to Identify Biomarkers of Response to Rigosertib
Collaboration builds off clinical data demonstrating rigosertib’s activity against PLK1 and may inform a precision medicine approach towards rigosertib’s evaluation...
Evaxion presents a new source of AI-derived immunotherapeutic targets strongly associated with the overall survival of cancer patients
Evaxion’s AI technology has led to the identification of new viral targets for cancer immunotherapyThis potentially enables treatment for patients...
Monte Rosa Therapeutics Appoints Dr. Jan Skvarka to Board of Directors
BOSTON, March 23, 2023 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE), a clinical stage biotechnology company developing novel...
Nanox.AI Expands Footprint Through New Global Partnership with Ferrum Health
Partnership with Ferrum Health offers unprecedented data security and an integrated AI platform to streamline health systems’ adoption of AI...
Gain Therapeutics to Participate in Virtual Fireside Chat On Computational Biology in Drug Discovery with Key Opinion Leaders
Panel, moderated by Hartaj Singh of Oppenheimer & Co., will be held on Wednesday, March 29, 2023 at 12:00 pm...
Syneos Health and KX Partner to Pioneer Data-Driven Transformation in Biopharmaceutical Asset Development
Collaboration Will Leverage Data Analytics and AI to Accelerate Clinical Trial ExecutionMORRISVILLE, N.C., March 22, 2023 (GLOBE NEWSWIRE) -- Syneos...
DiagnaMed Announces Dr. Bassma Ghali as Vice President of Product
Former Reliq Health Technologies Chief Innovation Officer and veteran product leader brings over a decade of experience building and commercializing...
Wave Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
Achieved clinical validation of PRISM platform in 2022 – demonstrated ability to potently and durably engage RNA targets and translate...
H1 Expands HCP Universe to Help Medical Affairs Understand and Track the Impact of Their Activities, Drive Adherence to Evidence-based Medicine, and Improve Patient Outcomes
New features provide real-time updates on the impact medical affairs teams are having on the HCP and HCO community to...
Monte Rosa Therapeutics Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
Phase 1/2 clinical trial evaluating MRT-2359 for treatment of MYC-driven solid tumors ongoingDisclosure of initial data from Phase 1 arm...